Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Landman

Showing results (111-120 of 133) with videos related to

Pageof 14
Sort By:
Journal of Diabetes|December 24, 2015
Dutch diabetes prevalence estimates (DUDE-1)Nanne Kleefstra, Gijs W D Landman, Kornelis J J Van Hateren, et al.
Plos One|December 31, 2009
The lipid profile and mortality risk in elderly type 2 diabetic patients: a ten-year follow-up study (ZODIAC-13)Kornelis J J van Hateren, Gijs W D Landman, Nanne Kleefstra, et al.
JAMA Internal Medicine|September 16, 2014
Efficacy of device-guided breathing for hypertension in blinded, randomized, active-controlled trials: a meta-analysis of individual patient dataGijs W D Landman, Kornelis J J van Hateren, Peter R van Dijk, et al.
BMJ Open|January 27, 2018
Association between body mass index and obesity-related cancer risk in men and women with type 2 diabetes in primary care in the Netherlands: a cohort study (ZODIAC-56)Steven H Hendriks, Dennis Schrijnders, Kornelis Jj van Hateren, et al.
Diabetes, Obesity & Metabolism|June 7, 2016
Addition of sulphonylurea to metformin does not relevantly change body weight: a prospective observational cohort study (ZODIAC-39)Dennis Schrijnders, Raiza Wever, Nanne Kleefstra, et al.
JAMA Internal Medicine|June 12, 2013
Device-guided breathing as treatment for hypertension in type 2 diabetes mellitus: a randomized, double-blind, sham-controlled trialGijs W D Landman, Iefke Drion, Kornelis J J van Hateren, et al.
BMC Cancer|June 25, 2017
Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) - a study protocolDennis Schrijnders, Geertruida H de Bock, Sebastiaan T Houweling, et al.
Plos One|March 17, 2015
Comparison of methods for renal risk prediction in patients with type 2 diabetes (ZODIAC-36)Ineke J Riphagen, Nanne Kleefstra, Iefke Drion, et al.
Plos One|August 29, 2009
Life expectancy in a large cohort of type 2 diabetes patients treated in primary care (ZODIAC-10)Helen L Lutgers, Esther G Gerrits, Wim J Sluiter, et al.
Diabetes Care|March 6, 2008
Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4)Nanne Kleefstra, Gijs W D Landman, Sebastiaan T Houweling, et al.
Pageof 14

Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Journal of Diabetes|December 24, 2015
Dutch diabetes prevalence estimates (DUDE-1)Nanne Kleefstra, Gijs W D Landman, Kornelis J J Van Hateren, et al.
Plos One|December 31, 2009
The lipid profile and mortality risk in elderly type 2 diabetic patients: a ten-year follow-up study (ZODIAC-13)Kornelis J J van Hateren, Gijs W D Landman, Nanne Kleefstra, et al.
JAMA Internal Medicine|September 16, 2014
Efficacy of device-guided breathing for hypertension in blinded, randomized, active-controlled trials: a meta-analysis of individual patient dataGijs W D Landman, Kornelis J J van Hateren, Peter R van Dijk, et al.
BMJ Open|January 27, 2018
Association between body mass index and obesity-related cancer risk in men and women with type 2 diabetes in primary care in the Netherlands: a cohort study (ZODIAC-56)Steven H Hendriks, Dennis Schrijnders, Kornelis Jj van Hateren, et al.
Diabetes, Obesity & Metabolism|June 7, 2016
Addition of sulphonylurea to metformin does not relevantly change body weight: a prospective observational cohort study (ZODIAC-39)Dennis Schrijnders, Raiza Wever, Nanne Kleefstra, et al.
JAMA Internal Medicine|June 12, 2013
Device-guided breathing as treatment for hypertension in type 2 diabetes mellitus: a randomized, double-blind, sham-controlled trialGijs W D Landman, Iefke Drion, Kornelis J J van Hateren, et al.
BMC Cancer|June 25, 2017
Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) - a study protocolDennis Schrijnders, Geertruida H de Bock, Sebastiaan T Houweling, et al.
Plos One|March 17, 2015
Comparison of methods for renal risk prediction in patients with type 2 diabetes (ZODIAC-36)Ineke J Riphagen, Nanne Kleefstra, Iefke Drion, et al.
Plos One|August 29, 2009
Life expectancy in a large cohort of type 2 diabetes patients treated in primary care (ZODIAC-10)Helen L Lutgers, Esther G Gerrits, Wim J Sluiter, et al.
Diabetes Care|March 6, 2008
Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4)Nanne Kleefstra, Gijs W D Landman, Sebastiaan T Houweling, et al.
Pageof 14